Pharmacokinetic interactions with rifampicin : clinical relevance von Niemi, Mikko, Backman, Janne T, Fromm, Martin F, Neuvonen, Pertti J, Kivistö, Kari T

Volltext

Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes von Niemi, Mikko, Cascorbi, Ingolf, Timm, Ramona, Kroemer, Heyo K., Neuvonen, Pertti J., Kivistö, Kari T.

Volltext

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions von Kivisto, KT, Kroemer, HK, Eichelbaum, M.

Volltext

The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide von Niemi, Mikko, Neuvonen, Pertti J., Kivistö, Kari T.

Volltext

Polymorphic Organic Anion Transporting Polypeptide 1B1 is a Major Determinant of Repaglinide Pharmacokinetics von Niemi, Mikko, Backman, Janne T., Kajosaari, Lauri I., Leathart, Julian B., Neuvonen, Mikko, Daly, Ann K., Eichelbaum, Michel, Kivistö, Kari T., Neuvonen, Pertti J.

Volltext

Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride von Niemi, Mikko, Kivistö, Kari T., Backman, Janne T., Neuvonen, Pertti J.

Volltext

The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron von Villikka, Kirsti, Kivistö, Kari T., Neuvonen, Pertti J.

Volltext

Cytochrome P450 3A4 and P-glycoprotein Expression in Human Small Intestinal Enterocytes and Hepatocytes: A Comparative Analysis in Paired Tissue Specimens von Richter, Oliver, Burk, Oliver, Fromm, Martin F., Thon, Klaus P., Eichelbaum, Michel, Kivistö, Kari T.

Volltext

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1) von Niemi, Mikko, Kivistö, Kari T., Hofmann, Ute, Schwab, Matthias, Eichelbaum, Michel, Fromm, Martin F.

Volltext

Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: A prospective clinical study von Fux, Richard, Mörike, Klaus, Pröhmer, Anne M.T., Delabar, Ursula, Schwab, Matthias, Schaeffeler, Elke, Lorenz, Gernot, Gleiter, Christoph H., Eichelbaum, Michel, Kivistö, Kari T.

Volltext

Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin von Lilja, Jari J., Kivistö, Kari T., Neuvonen, Pertti J.

Volltext

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole von Neuvonen, Pertti J., Kantola, Teemu, Kivistö, Kari T.

Volltext

Concentrations and effects of buspirone are considerably reduced by rifampicin von Lamberg, T. S., Kivistö, K. T., Neuvonen, P. J.

Volltext

Plasma concentrations of active simvastatin acid are increased by gemfibrozil von Backman, Janne T., Kyrklund, Carl, Kivistö, Kari T., Wang, Jun‐Sheng, Neuvonen, Pertti J.

Volltext

Effect of itraconazole on the pharmacokinetics of atorvastatin von Kantola, Teemu, Kivistö, Kari T., Neuvonen, Pertti J.

Volltext

Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations von Kantola, Teemu, Kivistö, Kari T., Neuvonen, Pertti J.

Volltext

Functional interaction of intestinal CYP3A4 and P-glycoprotein von Kivistö, Kari T., Niemi, Mikko, Fromm, Martin F.

Volltext

Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate von Kyrklund, Carl, Backman, Janne T., Kivistö, Kari T., Neuvonen, Mikko, Laitila, Jouko, Neuvonen, Pertti J.

Volltext

Grapefruit juice-simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors von Lilja, Jari J., Kivistö, Kari T., Neuvonen, Pertti J.

Volltext

Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin von Lilja, Jari J., Kivistö, Kari T., Neuvonen, Pertti J.

Volltext